The relationship between nonalcoholic fatty liver disease and colorectal cancer: The future challenges and outcomes of the metabolic syndrome

Journal of Obesity

Volumn 2012, Issue , 2012, Pages

  Muhidin, Said O ^a   Magan, Ahmed A ^b   Osman, Khalid A ^c   Syed, Shareef ^d   Ahmed, Mohamed H ^e  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^d CENTRAL MICHIGAN UNIVERSITY   (United States)

^e WEXHAM PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BEVACIZUMAB; GROWTH HORMONE; HEMOGLOBIN A1C; LEPTIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ABDOMINAL OBESITY; ADIPOCYTE; APOPTOSIS; BODY MASS; CELL PROLIFERATION; COLON POLYPOSIS; COLORECTAL ADENOMA; COLORECTAL CANCER; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLYCEMIC INDEX; GLYCEMIC LOAD; HUMAN; HYPERLIPIDEMIA; HYPOADIPONECTINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID STORAGE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; REVIEW; COLORECTAL TUMOR; COMORBIDITY; FATTY LIVER; OBESITY;

COLORECTAL NEOPLASMS; COMORBIDITY; DYSLIPIDEMIAS; FATTY LIVER; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY;

MLCS; MLOWN;

EID: 84872150627     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2012/637538     Document Type: Review

References (71)

1. Touzin N. T., Bush K. N. V., Williams C. D., Harrison S. A., Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2011 4 3 169 176 10.1177/ 1756283X11402118
2. Thorne A. L., Mercer S. J., Harris G. J. C., Simson J. N. L., Reduction in late diagnosis of colorectal cancer following introduction of a specialist colorectal surgery service. Annals of the Royal College of Surgeons of England 2006 88 6 562 565 2-s2.0-33750198779 10.1308/003588406X130688 (Pubitemid 44596462)
3. Edwards B. K., Brown M. L., Wingo P. A., Howe H. L., Ward E., Ries L. A. G., Schrag D., Jamison P. M., Jemal A., Wu X. C., Friedman C., Harlan L., Warren J., Anderson R. N., Pickle L. W., Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. Journal of the National Cancer Institute 2005 97 19 1407 1427 2-s2.0-26944473246 10.1093/jnci/dji289 (Pubitemid 41520077)
4. Byeon J. S., Yang S. K., Kim T. I., Kim W. H., Lau J. Y. W., Leung W. K., Fujita R., Makharia G. K., Abdullah M., Hilmi I., Sollano J., Yeoh K. G., Wu D. C., Chen M. H., Kongkam P., Sung J. J. Y., Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointestinal Endoscopy 2007 65 7 1015 1022 2-s2.0-34249086540 10.1016/j.gie.2006.12.065 (Pubitemid 46783822)
5. Reilly M. P., Rader D. J., The metabolic syndrome: more than the sum of its parts? Circulation 2003 108 13 1546 1551 2-s2.0-0141730248 10.1161/01.CIR.0000088846.10655.E0 (Pubitemid 37187778)
6. Tilg H., Diehl A. M., NAFLD and extrahepatic cancers: have a look at the colon. Gut 2011 60 6 745 746 2-s2.0-79955860802 10.1136/gut.2011.239392
7. Hwang S. T., Cho Y. K., Park J. H., Kim H. J., Park D. I., Sohn C. I., Jeon W. K., Kim B. I., Won K. H., Jin W., Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. Journal of Gastroenterology and Hepatology 2010 25 3 562 567 2-s2.0-77649226704 10.1111/j.1440-1746.2009.06117.x
8. Ahmed M. H., Byrne C. D., Non-alcoholic fatty liver disease. The Metabolic Syndrome 2011 Wiley-Blackwell 245 277
9. Ahmed M. H., Byrne C. D., Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discovery Today 2007 12 17-18 740 747 2-s2.0-34548392209 10.1016/j.drudis.2007.07.009 (Pubitemid 47362786)
10. Ahmed M. H., Abu E. O., Byrne C. D., Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities? Primary Care Diabetes 2010 4 3 129 137 2-s2.0-77957332990 10.1016/j.pcd.2010.02.004
11. Ahmed M. H., Byrne C. D., Obstructive sleep apnea syndrome and fatty liver: association or causal link? World Journal of Gastroenterology 2010 16 34 4243 4252 2-s2.0-77957569174 10.3748/wjg.v16.i34.4243
12. Byrne C. D., Olufad R., Bruce K. D., Cagampang F. R., Ahmed M. H., Metabolic disturbances in non-alcoholic fatty liver disease. Clinical Science 2009 116 7 539 564 2-s2.0-65549122652 10.1042/CS20080253
13. Giovannucci E., Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. The American Journal of Clinical Nutrition 2007 86 3 s836 842 2-s2.0-40349105880
14. Szczepaniak L. S., Nurenberg P., Leonard D., Browning J. D., Reingold J. S., Grundy S., Hobbs H. H., Dobbins R. L., Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. American Journal of Physiology 2005 288 2 E462 E468 2-s2.0-12144259379 10.1152/ajpendo.00064.2004 (Pubitemid 40110657)
15. Bellentani S., Saccoccio G., Masutti F., Crocè L. S., Brandi G., Sasso F., Cristanini G., Tiribelli C., Prevalence of and risk factors for hepatic steatosis in northern Italy. Annals of Internal Medicine 2000 132 2 112 117 2-s2.0-0033982172 (Pubitemid 30044177)
16. Ahmed M. H., Byrne C. D., Packard C. J., Metabolic syndrome, diabetes & CHD risk. The Year in Lipid Disorders 2007 Oxford, UK Clinical Publishing 3 26
17. Ahmed M. H., Byrne C. D., Current treatment of non-alcoholic fatty liver disease. Diabetes, Obesity and Metabolism 2009 11 3 188 195 2-s2.0-59349107500 10.1111/j.1463-1326.2008.00926.x
18. Ahmed M. H., Biochemical markers: the road map for the diagnosis of nonalcoholic fatty liver disease. American Journal of Clinical Pathology 2007 127 1 20 22 2-s2.0-34249053560 10.1309/JXWUM661T8VT1ETX (Pubitemid 46797013)
19. Adams L. A., Lymp J. F., Sauver J. S., Sanderson S. O., Lindor K. D., Feldstein A., Angulo P., The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005 129 1 113 121 2-s2.0-22344452893 10.1053/j.gastro.2005.04.014 (Pubitemid 41002048)
20. Adams L. A., Harmsen S., Sauver J. L. S., Charatcharoenwitthaya P., Enders F. B., Therneau T., Angulo P., Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. American Journal of Gastroenterology 2010 105 7 1567 1573 2-s2.0-77954424925 10.1038/ajg.2010.18
21. Wong V. W. S., Wong G. L. H., Tsang S. W. C., Fan T., Chu W. C. W., Woo J., Chan A. W. H., Choi P. C. L., Chim A. M. L., Lau J. Y. W., Chan F. K. L., Sung J. J. Y., Chan H. L. Y., High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011 60 6 829 836 2-s2.0-79955804203 10.1136/gut.2011.237974
22. Lee Y. I., Lim Y.-S., Park H. S., Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study. Journal of Gastroenterology and Hepatology 2012 27 1 91 95 10.1111/j.1440-1746. 2011.06816.x
23. Stadlmayr A., Aigner E., Steger B., Scharinger L., Lederer D., Mayr A., Strasser M., Brunner E., Heuberger A., Hohla F., Steinwendner J., Patsch W., Datz C., Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. Journal of Internal Medicine 2011 270 1 41 49 2-s2.0-79959344354 10.1111/j.1365-2796.2011.02377.x
24. Wong V. W., Hui A. Y., Tsang S. W., Chan J. L., Tse A. M., Chan K. F., So W. Y., Cheng A. Y., Ng W. F., Wong G. L., Sung J. J., Chan H. L., Metabolic and Adipokine Profile of Chinese Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 2006 4 9 1154 1161 2-s2.0-33748184089 10.1016/j.cgh.2006.06.011 (Pubitemid 44311653)
25. Hui J. M., Hodge A., Farrell G. C., Kench J. G., Kriketos A., George J., Beyond insulin resistance in NASH: TNF- α or adiponectin? Hepatology 2004 40 1 46 54 2-s2.0-3042744737 10.1002/hep.20280 (Pubitemid 38868922)
26. Wong V. W. S., Wong G. L. H., Tsang S. W. C., Hui A. Y., Chan A. W. H., Choi P. C. L., So W. Y., Tse A. M. L., Chan F. K. L., Sung J. J. Y., Chan H. L. Y., Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. Journal of Gastroenterology and Hepatology 2008 23 6 914 921 2-s2.0-44949172829 10.1111/j.1440-1746.2008. 05344.x (Pubitemid 351806578)
27. Unger R. H., Scherer P. E., Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends in Endocrinology and Metabolism 2010 21 6 345 352 2-s2.0-77953356804 10.1016/j.tem.2010.01.009
28. Yamaji T., Iwasaki M., Sasazuki S., Tsugane S., Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Research 2010 70 13 5430 5437 2-s2.0-77954353057 10.1158/0008-5472.CAN-10-0178
29. Sugiyama M., Takahashi H., Hosono K., Endo H., Kato S., Yoneda K., Nozaki Y., Fujita K., Yoneda M., Wada K., Nakagama H., Nakajima A., Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. International Journal of Oncology 2009 34 2 339 344 2-s2.0-64549123567 10.3892/ijo-00000156
30. Fujisawa T., Endo H., Tomimoto A., Sugiyama M., Takahashi H., Saito S., Inamori M., Nakajima N., Watanabe M., Kubota N., Yamauchi T., Kadowaki T., Wada K., Nakagama H., Nakajima A., Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 2008 57 11 1531 1538 2-s2.0-54349120590 10.1136/gut.2008.159293
31. Wei E. K., Giovannucci E., Fuchs C. S., Willett W. C., Mantzoros C. S., Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. Journal of the National Cancer Institute 2005 97 22 1688 1694 2-s2.0-27944506001 10.1093/jnci/dji376 (Pubitemid 41672235)
32. Kim A. Y., Lee Y. S., Kim K. H., Lee J. H., Lee H. K., Jang S. H., Kim S. E., Lee G. Y., Lee J. W., Jung S. A., Chung H. Y., Jeong S., Kim J. B., Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Molecular Endocrinology 2010 24 7 1441 1452 2-s2.0-77954828973 10.1210/me.2009-0498
33. Bråkenhielm E., Veitonmäki N., Cao R., Kihara S., Matsuzawa Y., Zhivotovsky B., Funahashi T., Cao Y., Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2004 101 8 2476 2481 2-s2.0-1442354888 10.1073/pnas.0308671100 (Pubitemid 38269336)
34. Ferroni P., Palmirotta R., Spila A., Martini F., Raparelli V., Fossile E., Mariotti S., Del Monte G., Buonomo O., Roselli M., Guadagni F., Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Research 2007 27 1 B 483 489 2-s2.0-33847732222 (Pubitemid 46374967)
35. Rose D. P., Komninou D., Stephenson G. D., Obesity, adipocytokines, and insulin resistance in breast cancer. Obesity Reviews 2004 5 3 153 165 2-s2.0-3242883351 10.1111/j.1467-789X.2004.00142.x (Pubitemid 38998240)
36. Stattin P., Lukanova A., Biessy C., Söderberg S., Palmqvist R., Kaaks R., Olsson T., Jellum E., Obesity and colon cancer: does leptin provide a link? International Journal of Cancer 2004 109 1 149 152 2-s2.0-0742270445 10.1002/ijc.11668 (Pubitemid 38160676)
37. Cowey S., Hardy R. W., The metabolic syndrome: a high-risk state for cancer? American Journal of Pathology 2006 169 5 1505 1522 2-s2.0-33947653911 10.2353/ajpath.2006.051090 (Pubitemid 351181984)
38. Trayhurn P., Wood I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004 92 3 347 355 2-s2.0-6944237757 10.1079/BJN20041213 (Pubitemid 40277057)
39. Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance. Journal of Clinical Investigation 2006 116 7 1793 1801 2-s2.0-33745861300 10.1172/JCI29069
40. Pittas A. G., Joseph N. A., Greenberg A. S., Adipocytokines and insulin resistance. Journal of Clinical Endocrinology and Metabolism 2004 89 2 447 452 2-s2.0-1442327902 10.1210/jc.2003-031005 (Pubitemid 38269842)
41. Sonnenberg G. E., Krakower G. R., Kissebah A. H., A novel pathway to the manifestations of metabolic syndrome. Obesity Research 2004 12 2 180 186 2-s2.0-2942698938 (Pubitemid 41132540)
42. Procaccini C., Galgani M., de Rosa V., Carbone F., la Rocca C., Ranucci G., Iorio R., Matarese G., Leptin: the prototypic adipocytokine and its role in nafld. Current Pharmaceutical Design 2010 16 17 1902 1912 2-s2.0-77953516574 10.2174/138161210791208884
43. Chiu H. M., Lin J. T., Shun C. T., Liang J. T., Lee Y. C., Huang S. P., Wu M. S., Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clinical Gastroenterology and Hepatology 2007 5 2 221 229 2-s2.0-33846890892 10.1016/j.cgh.2006.06.022 (Pubitemid 46223651)
44. Pais R., Silaghi H., Silaghi A. C., Rusu M. L., Dumitrascu D. L., Metabolic syndrome and risk of subsequent colorectal cancer. World Journal of Gastroenterology 2009 15 41 5141 5148 2-s2.0-73449136124 10.3748/wjg.15.5141
45. Aleksandrova K., Boeing H., Jenab M., Bueno-de-Mesquita H. B., Jansen E., Van Duijnhoven F. J. B., Fedirko V., Rinaldi S., Romieu I., Metabolic syndrome and risks of colon and rectal cancer: the european prospective investigation into cancer and nutrition study. Cancer Prevention Research 2011 4 11 1873 1883 10.1158/1940-6207.CAPR-11-0218
46. Calle E. E., Rodriguez C., Walker-Thurmond K., Thun M. J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. New England Journal of Medicine 2003 348 17 1625 1638 2-s2.0-0037464510 10.1056/NEJMoa021423 (Pubitemid 36459468)
47. Ahmed R. L., Schmitz K. H., Anderson K. E., Rosamond W. D., Folsom A. R., The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006 107 1 28 36 2-s2.0-33745401508 10.1002/cncr.21950 (Pubitemid 43941640)
48. Trevisan M., Liu J., Muti P., Misciagna G., Menotti A., Fucci F., Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiology Biomarkers and Prevention 2001 10 9 937 941 2-s2.0-0034851246 (Pubitemid 32844900)
49. Colangelo L. A., Gapstur S. M., Gann P. H., Dyer A. R., Liu K., Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiology Biomarkers and Prevention 2002 11 4 385 391 2-s2.0-0036123618 (Pubitemid 34408218)
50. Kabat G. C., Kim M. Y., Peters U., Stefanick M., Hou L., Wactawski-Wende J., Messina C., Shikany J. M., Rohan T. E., A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women. European Journal of Cancer Prevention 2012 21 4 326 332 10.1097/CEJ. 0b013e32834dbc81
51. Hsu Y.-C., Chiu H.-M., Liou J.-M., Chang C.-C., Lin J.-T., Liu H.-H., Wu M.-S., Glycated hemoglobin A1c is superior to fasting plasma glucose as an independent risk factor for colorectal neoplasia. Cancer Causes and Control 2012 23 2 321 328 10.1007/s10552-011-9880-y
52. Khaw K. T., Wareham N., Bingham S., Luben R., Welch A., Day N., Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European Prospective Investigation into Cancer-Norfolk Study. Cancer Epidemiology Biomarkers and Prevention 2004 13 6 915 919 2-s2.0-2942595911 (Pubitemid 38756700)
53. Schoen R. E., Tangen C. M., Kuller L. H., Burke G. L., Cushman M., Tracy R. P., Dobs A., Savage P. J., Increased blood glucose and insulin, body size, and incident colorectal cancer. Journal of the National Cancer Institute 1999 91 13 1147 1154 2-s2.0-0033532877 (Pubitemid 29330553)
54. Saydah S. H., Platz E. A., Rifai N., Pollak M. N., Brancati F. L., Helzlsouer K. J., Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiology Biomarkers and Prevention 2003 12 5 412 418 2-s2.0-0038623646 (Pubitemid 36578478)
55. Mulholland H. G., Murray L. J., Cardwell C. R., Cantwell M. M., Glycemic index, glycemic load, and risk of digestive tract neoplasms: a systematic review and meta-analysis. American Journal of Clinical Nutrition 2009 89 2 568 576 2-s2.0-59649123183 10.3945/ajcn.2008.26823
56. Sandhu M. S., Dunger D. B., Giovannucci E. L., Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. Journal of the National Cancer Institute 2002 94 13 972 980 2-s2.0-0037014743 (Pubitemid 34814726)
57. Grimberg A., Cohen P., Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. Journal of Cellular Physiology 2000 183 1 1 9 10.1002/(SICI)1097-4652(200004)183:1<1::AID- JCP1>3.0.CO;2-J (Pubitemid 30130219)
58. Warren R. S., Yuan H., Matli M. R., Ferrara N., Donner D. B., Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. Journal of Biological Chemistry 1996 271 46 29483 29488 2-s2.0-0029805574 10.1074/jbc.271.46.29483 (Pubitemid 26382669)
59. Jenkins P. J., Acromegaly and cancer. Hormone Research 2004 62 supplement 1 108 115 2-s2.0-17244362859 10.1159/000080768 (Pubitemid 40529159)
60. Giovannucci E., Pollak M. N., Platz E. A., Willett W. C., Stampfer M. J., Majeed N., Colditz G. A., Speizer F. E., Hankinson S. E., A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiology Biomarkers and Prevention 2000 9 4 345 349 (Pubitemid 30265776)
61. Williams A. C., Collard T. J., Perks C. M., Newcomb P., Moorghen M., Holly J. M. P., Paraskeva C., Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Research 2000 60 1 22 27 2-s2.0-0033972178 (Pubitemid 30058723)
62. De Gonzalez A. B., Hartge P., Cerhan J. R., Flint A. J., Hannan L., MacInnis R. J., Moore S. C., Tobias G. S., Anton-Culver H., Freeman L. B., Beeson W. L., Clipp S. L., English D. R., Folsom A. R., Freedman D. M., Giles G., Hakansson N., Henderson K. D., Hoffman-Bolton J., Hoppin J. A., Koenig K. L., Lee I. M., Linet M. S., Park Y., Pocobelli G., Schatzkin A., Sesso H. D., Weiderpass E., Willcox B. J., Wolk A., Zeleniuch-Jacquotte A., Willett W. C., Thun M. J., Body-mass index and mortality among 1.46 million white adults. New England Journal of Medicine 2010 363 23 2211 2219 2-s2.0-78649747039 10.1056/NEJMoa1000367
63. Moghaddam A. A., Woodward M., Huxley R., Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiology Biomarkers and Prevention 2007 16 12 2533 2547 2-s2.0-38849087252 10.1158/1055-9965.EPI-07-0708 (Pubitemid 351196307)
64. Morois S., Mesrine S., Josset M., Clavel-Chapelon F., Boutron-Ruault M. C., Anthropometric factors in adulthood and risk of colorectal adenomas. American Journal of Epidemiology 2010 172 10 1166 1180 2-s2.0-78149337544 10.1093/aje/kwq258
65. Stein B., Anderson J. C., Rajapakse R., Alpern Z. A., Messina C. R., Walker G., Body mass index as a predictor of colorectal Neoplasia in ethnically diverse screening population. Digestive Diseases and Sciences 2010 55 10 2945 2952 2-s2.0-77957915915 10.1007/s10620-009-1113-9
66. Wang Y., Jacobs E. J., Patel A. V., Rodríguez C., McCullough M. L., Thun M. J., Calle E. E., A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence. Cancer Causes and Control 2008 19 7 783 792 2-s2.0-48149103233 10.1007/s10552-008-9141-x
67. Pischon T., Lahmann P. H., Boeing H., Friedenreich C., Norat T., Tjønneland A., Halkjaer J., Overvad K., Clavel-Chapelon F., Boutron-Ruault M. C., Guernec G., Bergmann M. M., Linseisen J., Becker N., Trichopoulou A., Trichopoulos D., Sieri S., Palli D., Tumino R., Vineis P., Panico S., Peeters P. H. M., Bueno-de-Mesquita H. B., Boshuizen H. C., Van Guelpen B., Palmqvist R., Berglund G., Gonzalez C. A., Dorronsoro M., Barricarte A., Navarro C., Martinez C., Quirós J. R., Roddam A., Allen N., Bingham S., Khaw K. T., Ferrari P., Kaaks R., Slimani N., Riboli E., Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Journal of the National Cancer Institute 2006 98 13 920 931 2-s2.0-33745774113 10.1093/jnci/djj246 (Pubitemid 44018922)
68. Tabuchi M., Kitayama J., Nagawa H., Hyperglycemia and hypertriglyceridemia may associate with the adenoma-carcinoma transition in colorectal epithelial cells. Journal of Gastroenterology and Hepatology 2008 23 6 985 987 2-s2.0-44949241791 10.1111/j.1440-1746.2007.05072.x (Pubitemid 351806568)
69. Tabuchi M., Kitayama J., Nagawa H., Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men. World Journal of Gastroenterology 2006 12 8 1261 1264 2-s2.0-33645522099
70. Liu C. S., Hsu H. S., Li C. I., Jan C. I., Li T. C., Lin W. Y., Lin T. T., Chen Y. C., Lee C. C., Lin C. C., Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterology 2010 10, article 51 2-s2.0-77952705576 10.1186/1471-230X-10-51
71. Bonovas S., Filioussi K., Flordellis C. S., Sitaras N. M., Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. Journal of Clinical Oncology 2007 25 23 3462 3468 2-s2.0-34548019063 10.1200/JCO.2007.10.8936 (Pubitemid 47310884)